SCHEMBL7779595

SCHEMBL7779595

CC=Cn1nc(-c2ccc(S(N)(=O)=O)cc2)c(-c2ccccc2C)c1C(F)(F)F

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 11/20 0.49
PTGS1 P23219 9/20 0.49
CA1 P00915 4/20 0.47
CA2 P00918 4/20 0.47
CA12 O43570 3/20 0.47
CA9 Q16790 3/20 0.47
PTGES O14684 2/20 0.39
PDPK1 O15530 5/20 0.39
CA5A P35218 3/20 0.39
CA5B Q9Y2D0 3/20 0.39
MT-CO2 P00403 2/20 0.39
LMNA P02545 2/20 0.39
CA3 P07451 2/20 0.39
CYP3A4 P08684 2/20 0.39
ADORA3 P0DMS8 2/20 0.39
ADRA2B P18089 2/20 0.39
CA4 P22748 2/20 0.39
CA6 P23280 2/20 0.39
SLC6A2 P23975 2/20 0.39
CA7 P43166 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7780843 0.91 PTGS2 (0.45) PTGS2PTGS1CYP2C9
SCHEMBL7780102 0.87 PTGS2 (0.54) PTGS2PTGS1CA1CA2CA12
SCHEMBL8631100 0.85 PTGS2 (0.39) PTGS2PTGS1CA1CA2CA12
SCHEMBL7773256 0.85 PTGS2 (0.54) PTGS2PTGS1CA1CA2CA12
SCHEMBL7778278 0.84 PTGS2 (0.54) PTGS2PTGS1CA1CA2CA12
SCHEMBL7780060 0.83 PTGS2 (0.66) PTGS2PTGS1CA1CA2CA12
SCHEMBL7779636 0.83 PTGS2 (0.50) PTGS2PTGS1CA1CA2CA12
SCHEMBL7777338 0.82 PTGS2 (0.53) PTGS2PTGS1CA1CA2CA12
SCHEMBL7773378 0.82 PTGS2 (0.53) PTGS2PTGS1CA1CA2CA12
SCHEMBL7773180 0.82 PTGS2 (0.53) PTGS2PTGS1CA1CA2CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0772597-B1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2001-12-12 EP disclosed
EP-1127878-A1 3,4 - substituted pyrazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-29 EP disclosed
US-6028072-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 2000-02-22 US disclosed
EP-0772597-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-05-14 EP disclosed
US-5580985-A ANTIARTHRITIC AGENT; SIDE EFFECT REDUCTION G. D. SEARLE & CO. (US) 1996-12-03 US disclosed
WO-1996003385-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-02-08 WO disclosed
US-5486534-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 1996-01-23 US disclosed